US2002091165A1PendingUtilityA1
Carboxyl-modified superabsorbent protein hydrogel
Priority: Feb 15, 2000Filed: Oct 29, 2001Published: Jul 11, 2002
Est. expiryFeb 15, 2020(expired)· nominal 20-yr term from priority
Inventors:Srinivasan Damodaran
C08L 89/00C08H 1/02C08H 1/00
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is a biodegradable, reversibly-swellable, polyvalent cation-binding, protein hydrogel which comprises an acylated protein matrix in which the acylated protein matrix is crosslinked with a bifunctional crosslinking reagent, and treated with a polar organic solvent, and a method of making the same.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A protein hydrogel comprising an acylated protein matrix, the acylated protein matrix being crosslinked with a bifunctional crosslinking reagent to yield a crosslinked protein matrix, the crosslinked protein matrix then being treated with a polar organic solvent.
2 . The protein hydrogel according to claim 1 , wherein the bifunctional crosslinking agent is a bifunctional aldehyde.
3 . The protein hydrogel according to claim 2 , wherein the bifunctional aldehyde is selected from the group consisting of
OCH—(CH2) x —CHO
wherein X is an integer of from 2 to 8.
4 . The protein hydrogel according to claim 1 , wherein the bifunctional crosslinking agent is glutaraldehyde.
5 . The protein hydrogel according to claim 1 , wherein the acylated protein matrix comprises a protein derived from biomass.
6 . The protein hydrogel according to claim 1 , wherein the acylated protein matrix comprises a protein concentrate derived from biomass.
7 . The protein hydrogel according to claim 1 , wherein the acylated protein matrix comprises a protein isolate derived from biomass.
8 . The protein hydrogel according to claim 7 , wherein the protein isolate is a fish protein isolate.
9 . The protein hydrogel according to claim 1 , wherein the acylated protein matrix is a protein treated with an acylating agent.
10 . The protein hydrogel according to claim 9 , wherein the acylating agent is an anhydride.
11 . The protein hydrogel according to claim 10 , wherein the acylating agent is a tetracarboxylic acid dianhydride.
12 . The protein hydrogel according to claim 10 , wherein the acylating agent is ethylenediaminetetraacetic acid dianhydride.
13 . The protein hydrogel according to claim 1 , wherein the polar organic solvent is selected from the group consisting of C 1 -C 4 alcohols, C 1 -C 4 ketones, and C 1 -C 4 aldehydes.
14 . The protein hydrogel according to claim 13 , wherein the polar organic solvent is selected from the group consisting of ethanol, propanol, butanol, and acetone.
15 . The protein hydrogel according to claim 14 , wherein the polar organic solvent comprises ethanol.
16 . A protein hydrogel comprising:
a fish protein isolate, the fish protein isolate being acylated by treatment with ethylenediaminetetraacetic acid dianhydride to yield an acylated protein; the acylated protein being crosslinked with glutaraldehyde to yield a crosslinked protein matrix; and the crosslinked protein matrix being treated with a polar organic solvent.
17 . A method of making a protein hydrogel, the method comprising the steps of:
(a) treating a protein with an acylating agent to yield an acylated protein; (b) crosslinking the acylated protein with a bifunctional crosslinking agent to yield a crosslinked protein; and (c) treating the crosslinked protein with a polar organic solvent.
18 . The method according to claim 17 , wherein in step (a) the protein is treated with an amount of acylating agent sufficient to acylate from about 1 to about 98% of lysine residues within the protein.
19 . The method according to claim 17 , wherein in step (a) the protein is treated with an anhydride.
20 . The method according to claim 17 , wherein in step (a) the protein is treated with a tetracarboxylic acid dianhydride.
21 . The method according to claim 20 , wherein in step (a) the protein is treated with ethylenediaminetetraacetic acid dianhydride.
22 . The method according to claim 20 , wherein in step (b) the acylated protein is crosslinked with a dialdehyde.
23 . The method according to claim 22 , wherein in step (b) the dialdehyde is selected from the group consisting of
OCH—(CH2) x —CHO
wherein X is an integer of from 2 to 8.
24 . The method according to claim 23 , wherein in step (b) the dialdehyde is glutaraldehyde.
25 . The method according to claim 17 , wherein:
in step (a) the acylating agent is added to an aqueous protein solution of about pH 12, at a temperature of about 65 to 100° C. to yield the acylated protein; and in step (b) crosslinking is effected by addition of glutaraldehyde to an aqueous solution of the acylated protein of step (a) to yield a crosslinked protein; and in step (c) the crosslinked protein is treated with a polar organic solvent selected from the group consisting of C 1 -C 4 alcohols, C 1 -C 4 ketones, and C 1 -C 4 aldehydes.
26 . The method according to claim 25 , wherein in step (c) the crosslinked protein is treated with a polar organic solvent selected from the group consisting of ethanol, propanol, butanol, and acetone.
27 . The method according to claim 26 , wherein in step (c) the crosslinked protein is treated with ethanol.Join the waitlist — get patent alerts
Track US2002091165A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.